Staying on track: Optimizing the lipid-lowering pathway whilst avoiding treatment gaps

Overview

Optimizing patients pathways and and filling the gap in the treatment paradigm , a journey through the European and American guidelines to identify the gaps and risk stratification of dyslipidemia patient

This Class for

• Clinical Pharmacy
• Pharmacy
• Physician
• Resident / Fellow

Related Classes

• Alirocumab: Focus on high CV risk patients and mortality outcomes in Odyssey
• How to prevent the Event in People with T2D and ASCVD